Goldan Keith A. insider trades
Goldan Keith A. has filed 19 Form 4s with the SEC that we hold, for Syndax Pharmaceuticals Inc (SNDX) (Chief Financial Officer), OPTN (Chief Financial Officer) and Abeona Therapeutics INC. (ABEO) (Director). Across all of them we count 2 purchases worth $25.0K and 9 sales worth $232.8K reported on Form 4. In the last 12 months: 0 purchases ($0) and 3 sales ($137.0K). The largest single trade was a sale of 3,410 shares of Syndax Pharmaceuticals Inc worth $71.7K, dated 2026-02-09. The first filing on our record is dated 2021-09-17 and the latest 2026-06-02.
Syndax Pharmaceuticals Inc (SNDX)
| Trade date | Code | Shares | Value as filed | Filed | Source |
|---|---|---|---|---|---|
| 2023-06-13 | S, sale reported on Form 4 | 577 | $12.9K | 2023-06-14 | SEC |
| 2024-06-14 | P, purchase reported on Form 4 | 1,250 | $25.0K | 2024-06-17 | SEC |
| 2025-02-10 | S, sale reported on Form 4 | 3,777 | $58.5K | 2025-02-12 | SEC |
| 2025-05-19 | P, purchase reported on Form 4 | 3,000 | - | 2025-05-19 | SEC |
| 2025-07-16 | S, sale reported on Form 4 | 1,296 | $12.0K | 2025-07-18 | SEC |
| 2026-02-06 | S, sale reported on Form 4 | 2,082 | $42.9K | 2026-02-06 | SEC |
| 2026-02-09 | S, sale reported on Form 4 | 3,410 | $71.7K | 2026-02-10 | SEC |
| 2026-06-01 | S, sale reported on Form 4 | 1,177 | $22.4K | 2026-06-02 | SEC |
OPTN
Abeona Therapeutics INC. (ABEO)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1495411) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
